LIVER CIRRHOSIS LIVER CIRRHOSIS. THE ANATOMY OF THE PORTAL VENOUS SYSTEM.

61
LIVER CIRRHOSIS LIVER CIRRHOSIS

Transcript of LIVER CIRRHOSIS LIVER CIRRHOSIS. THE ANATOMY OF THE PORTAL VENOUS SYSTEM.

LIVER CIRRHOSIS LIVER CIRRHOSIS

THE ANATOMY

OF THE PORTAL VENOUS SYSTEM

LIVER CIRRHOSISLIVER CIRRHOSIS

Diffuse disorganization of normal Diffuse disorganization of normal hepatic structure by regenerative hepatic structure by regenerative nodules that are surrounded by nodules that are surrounded by fibrotic tissue.fibrotic tissue.

NORMALNORMAL

Metabolism – Carbohydrate, Fat & ProteinSecretory – bile, Bile acids, salts & pigmentsExcretory – Bilirubin, drugs, toxinsSynthesis – Albumin, coagulation factorsStorage – Vitamins, carbohydrates etc.Detoxification – toxins, ammonia, etc.

Liver Functions

Normal Liver - MicroscopyNormal Liver - Microscopy

Micronodular CirrhosisMicronodular Cirrhosis

Macronodular CirrhosisMacronodular Cirrhosis

PATHOMORPHOLOGYPATHOMORPHOLOGY

PATHOMORPHOLOGYPATHOMORPHOLOGY

Liver Biopsy – CirrhosisLiver Biopsy – Cirrhosis

LIVER CIRRHOSISLIVER CIRRHOSIS CLASSIFICATIONCLASSIFICATION (etiologic) (etiologic)

VViraliral

AlcoholicAlcoholic

ToxicToxic

AutoimmuneAutoimmune

MetabolicMetabolic

ССongestiveongestive

BiliaryBiliary

CCryptogenic ryptogenic

LIVER CIRRHOSISLIVER CIRRHOSIS CLASSIFICATIONCLASSIFICATION

CLASSIFICATION CLASSIFICATION ((HistopathologicHistopathologic ))

MicronodularMicronodular (nodules(nodules < 3 < 3 mm mm

in diameter)in diameter)

MacronodularMacronodular(nodules(nodules >> 3 3 mm mm

in diameter)in diameter)

MixedMixed

LIVER CIRRHOSISLIVER CIRRHOSIS CLASSIFICATIONCLASSIFICATION

DEGREE OF PROGRESSDEGREE OF PROGRESS AND PROCESSAND PROCESS

ACTIVITYACTIVITY

ACTIVEACTIVE NONACTIVE

QuicklyQuickly progressiveprogressive

SlowlySlowly progressiveprogressive

Latent

LIVER CIRRHOSISLIVER CIRRHOSIS CLASSIFICATIONCLASSIFICATION

SEVERITY OF DISEASE

Compensation stage

Subcompensation stage

Decompensation stage

CLASSIFICATION according toCLASSIFICATION according to Child - Turcotte and Pugh Child - Turcotte and Pugh

ParameterParameter

Class A

Compensation

(5-6 points)

Class BSubcompensation

(7-9 points)

Class C

Decompensation (10 and >points)

Bilirubin, mcmol/lBilirubin, mcmol/l <35<35 35-5535-55 >55>55Albumine, g/l >35>35 30-3530-35 <30<30Prothrombin index 60-80%60-80% 40-59%40-59% <40%<40%AscitesAscites absentabsent treatabletreatable untreatableuntreatableEncephalopathy Encephalopathy absentabsent 1-2 st.1-2 st. 3-4 st.3-4 st.

PointsPoints:: 11 22 33

LIVER CIRRHOSISLIVER CIRRHOSISССOMPLICATIONSOMPLICATIONS

HEPATIC HEPATIC ENCEPHALOPATHY ENCEPHALOPATHY

VVARICEAL BLEEDINGARICEAL BLEEDING

ASCITESASCITES

HEPATORENAL SYNDROMEHEPATORENAL SYNDROME

PORTAL VEIN TROMBOSISPORTAL VEIN TROMBOSIS

BACTERIAL BACTERIAL

PERITONITISPERITONITIS

HEPATOCARCINOMAHEPATOCARCINOMA

LIVER CIRRHOSISLIVER CIRRHOSIS CLINICAL SYNDROMES CLINICAL SYNDROMES

Astenic syndrome Astenic syndrome

Pain syndromePain syndrome

Dyspeptic syndromeDyspeptic syndrome

Cholestatic Cholestatic syndromesyndrome

Syndrome of jaundiceSyndrome of jaundice

Portal HypertensionPortal Hypertension

Spider naevus in liver cirrhosis in the ventral side of the

left shoulder

Palmar erythema in liver cirrhosis

Gynaecomastia in liver cirrhosis

Xanthelasmas in biliary cirrhosis as a result of primary

biliary cholangitis

Vein dilatation in the abdominal wall of a cirrhotic patient suffering from ascites and jaundice

ASCITES

Jaundice

Ascitis in CirrhosisAscitis in Cirrhosis

Micronodular cirrhosis:Micronodular cirrhosis:

Micronodular cirrhosis:Micronodular cirrhosis:

Alcoholic HepatitisAlcoholic Hepatitis

Macronodular CirrhosisMacronodular Cirrhosis

Liver Biopsy – CirrhosisLiver Biopsy – Cirrhosis

Liver Biopsy – Cirrhosis:Liver Biopsy – Cirrhosis:

Nutmeg Liver-Cardiac SclerosisNutmeg Liver-Cardiac Sclerosis

Clinical FeaturesClinical Features

Hepatocellular failure.Hepatocellular failure.– Malnutrition, low albumin & clotting Malnutrition, low albumin & clotting

factors, bleeding.factors, bleeding.– Hepatic encephalopathy.Hepatic encephalopathy.

Portal hypertension.Portal hypertension.– Ascites, Portal systemic shunts, Ascites, Portal systemic shunts,

varices, splenomegaly.varices, splenomegaly.

Bleeding in Liver disease:Bleeding in Liver disease:

vitamin K – in liver vitamin K – in liver gamma-gamma-carboxyglutamic acid – for coagulation carboxyglutamic acid – for coagulation factors II, VII, IX, and X. factors II, VII, IX, and X.

Liver disease Liver disease factor VII is the first to go factor VII is the first to go so the defect will appear initially in the so the defect will appear initially in the extrinsic pathway, i.e., abnormal PT. extrinsic pathway, i.e., abnormal PT. When severe it affects both pathways.When severe it affects both pathways.

CirrhosisCirrhosisClinical Clinical

FeaturesFeatures

Gynaecomastia in cirrhosisGynaecomastia in cirrhosis

Porta-systemic anastomosis: Porta-systemic anastomosis: Prominent abdominal veins.Prominent abdominal veins.

MRI CirrhosisMRI Cirrhosis

Complications:Complications:Congestive splenomegaly.Congestive splenomegaly.Bleeding varices.Bleeding varices.Hepatocellular failure.Hepatocellular failure.– Hepatic encephalitis / hepatic coma.Hepatic encephalitis / hepatic coma.Hepatocellular carcinoma.Hepatocellular carcinoma.

Hepatocellular CarcinomaHepatocellular Carcinoma

LIVER CIRRHOSISLIVER CIRRHOSIS PLAN of INVESTIGATIONSPLAN of INVESTIGATIONS

Total blood count, Blood group and Rhesus factorBiochemical analysis (Glucose, Bilirubin, ALT, AST, GGT, Alkaline phosphatase, Albumin, الال-globulins, -globulins, Cholesterol, Cholesterol, Liver tests, Sodium, Potassium, Urea, Creatinine)Urinanalysis, Diastase of urineCoagulogramMarkers of VViral iral HHepatitisepatitis (chain polimerase reaction, (chain polimerase reaction, immunoenzyme analysis)immunoenzyme analysis)ImmunogramImmunogramECG, Endoscopy, USD, CT, EEGDiagnostic paracentesisNeedle liver biopsy

Diagnostic paracentesis.

Endoscopy reveals large, tortuous Endoscopy reveals large, tortuous esophageal varices thatesophageal varices that

have a characteristic bluish colorhave a characteristic bluish color

ESOPHAGEAL ESOPHAGEAL VARICESVARICES

Normal liver with portal vein (VP), inferior vena Normal liver with portal vein (VP), inferior vena cava (VC) and right branch of the portal vein (RHA). cava (VC) and right branch of the portal vein (RHA).

Subcostal plane: 1 - left branch of VP; 2 - right Subcostal plane: 1 - left branch of VP; 2 - right

branch of hepatic vein; 3 - cranial diaphragmbranch of hepatic vein; 3 - cranial diaphragm

Liver cirrhosis with ascites Liver cirrhosis with ascites (longitudinal section): the (longitudinal section): the left lobe of liver is rounded left lobe of liver is rounded and plump; intrahepatic and plump; intrahepatic vessels are reduced. vessels are reduced. Irregular and Irregular and inhomogeneous structure. inhomogeneous structure. Clear undulatory limitation Clear undulatory limitation (arrow) on the underside (arrow) on the underside due to nodular due to nodular transformation.transformation.Wide hypoechoic fringe Wide hypoechoic fringe due to ascitesdue to ascites

Post mortem specimen of cirrhotic liver and enlarged spleen Post mortem

specimen of banded oesophageal varix

Monitoring of patients

with ascites

TREATMENT

LIVER CIRRHOSISLIVER CIRRHOSIS TREATMENTTREATMENT

Diet №5CCORTICOSTEROIDORTICOSTEROID THERAPY(Prednisolone), Prednisolone), IMMUNOSUPPRESSIVE THERAPY(Azathioprine))HEPATOPROTECTORSDIURETICS (potassium sparing diuretic (Spironolactone 150-200 mg/day) +loop diuretic (Furosemid 20-80mg/day))DEZINTOXICATION THERAPYVITAMIN VITAMIN THERAPYLACTULOSE (30 ml 3 times/day orally)DIGESTIVE ENZYMESCORRECTION OF CORRECTION OF ELECTROLYTE BALANCEELECTROLYTE BALANCE DISTURBANCEDISTURBANCESYMTOMATIC THERAPYLIVER TRANSPLANTATION

Liver transplantation

Liver transplantation should be considered for most patients with end-stage liver disease or acute fulminant hepatic failure, and transplant units should be contacted early regarding referral.

LIVER CIRRHOSISLIVER CIRRHOSISССOMPLICATIONSOMPLICATIONS

HEPATIC ENCEPHALOPATHYHEPATIC ENCEPHALOPATHY

VVARICEAL BLEEDINGARICEAL BLEEDING

ASCITESASCITES

HEPATORENAL SYNDROMEHEPATORENAL SYNDROME

PORTAL VEIN TROMBOSISPORTAL VEIN TROMBOSIS

BACTERIAL PERITONITISBACTERIAL PERITONITIS

HEPATOCARCINOMAHEPATOCARCINOMA

Events precipitating hepatic Events precipitating hepatic encephalopathy inencephalopathy incirrhotic patientscirrhotic patients

Electrolyte imbalanceElectrolyte imbalance

DiureticsDiuretics

VomitingVomiting

DiarrhoeaDiarrhoea

Gastrointestinal bleedingGastrointestinal bleeding

DrugsDrugs

AlcoholAlcohol

InfectionInfection

SpontaneousSpontaneous

bacterial peritonitisbacterial peritonitis

UrinaryUrinary

ChestChest

ConstipationConstipation

Dietary protein Dietary protein overload overload

Drugs that can cause hepaticDrugs that can cause hepaticencephalopathyencephalopathy

BarbituratesBarbiturates

AnalgesicsAnalgesics

Other sedativesOther sedatives

Treatment of hepatic Treatment of hepatic encephalopathyencephalopathy

Identify the precipitating factorsIdentify the precipitating factorsStop diureticsStop diureticsCheck serum Na+, K+, and urea concentrationCheck serum Na+, K+, and urea concentrationEmpty bowels of nitrogen containing contentEmpty bowels of nitrogen containing contentControl bleedingControl bleedingProtein free dietProtein free dietLactuloseLactuloseNeomycin (1 g four times a day by mouth for 1 Neomycin (1 g four times a day by mouth for 1 week)week)Maintain energy, fluid, and electrolyte balanceMaintain energy, fluid, and electrolyte balanceIncrease dietary protein slowly with recoveryIncrease dietary protein slowly with recovery

LIVER CIRRHOSISLIVER CIRRHOSISССOMPLICATIONSOMPLICATIONS

HEPATIC ENCEPHALOPATHY HEPATIC ENCEPHALOPATHY

VVARICEAL BLEEDINGARICEAL BLEEDING

ASCITESASCITES

HEPATORENAL SYNDROMEHEPATORENAL SYNDROME

PORTAL VEIN TROMBOSISPORTAL VEIN TROMBOSIS

BACTERIAL PERITONITISBACTERIAL PERITONITIS

HEPATOCARCINOMAHEPATOCARCINOMA

Characteristic findings associated with Characteristic findings associated with hepatorenalhepatorenal syndromesyndrome

Ascites (but not necessarily jaundice) is usually Ascites (but not necessarily jaundice) is usually presentpresent

Hyponatraemia is usualHyponatraemia is usual

Hepatic encephalopathy is commonly presentHepatic encephalopathy is commonly present

Blood pressure is reduced compared with Blood pressure is reduced compared with previous pressuresprevious pressures recorded in patientrecorded in patient

Pronounced oliguriaPronounced oliguria

Low renal sodium concentrationLow renal sodium concentration

Urinary protein and casts are minimal or absentUrinary protein and casts are minimal or absent

Summary pointsSummary points

Cirrhosis is the commonest cause of ascites Cirrhosis is the commonest cause of ascites (90%)(90%)Ninety per cent of cases can be managed by Ninety per cent of cases can be managed by sodium restriction andsodium restriction and diureticsdiureticsHepatic encephalopathy is most commonly Hepatic encephalopathy is most commonly precipitated by drugsprecipitated by drugs or gastrointestinal or gastrointestinal haemorrhagehaemorrhageNon steroidal anti inflammatory drugs should be Non steroidal anti inflammatory drugs should be avoided inavoided in cirrhotic patients as they can cause cirrhotic patients as they can cause renal failurerenal failure

Summary pointsSummary pointsPORTAL HYPERTENSION

Normal portal vein pressure is 7 mmHg and pressure is usually above 12 mmHg when oesophageal varices develop.The majority of the oxygen supply of the liver comes from the portal vein, owing to its high flow compared to that in the hepatic artery.Portal hypertension has prehepatic, intrahepatic and post-hepatic causes.Patients with stable portal hypertension should be given beta-blockers.Treatment of ascites requires both dietary salt restriction and diuretics.Fluid restriction is only necessary if hyponatraemia develops.